Water treatment membrane production method, water treatment membrane produced using same, and water treatment module comprising water treatement membrane
US-2018178170-A1 · Jun 28, 2018 · US
US11718712B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-11718712-B2 |
| Application number | US-201916756652-A |
| Country | US |
| Kind code | B2 |
| Filing date | Jun 20, 2019 |
| Priority date | Jun 20, 2018 |
| Publication date | Aug 8, 2023 |
| Grant date | Aug 8, 2023 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
Provided is a composition for interfacial polymerizing polyamide including an amine compound; and one or more types of compounds selected from among a purine-based compound and a pyrimidine-based compound of Chemical Formula 1: wherein, in Chemical Formula 1: X is N or NH; Y is O or OH; Z is O, OH or NH 2 ; R1 and R2 are each hydrogen or a substituted or unsubstituted alkyl group; and is a single bond or a double bond, and a method for manufacturing a water-treatment membrane and a water-treatment membrane using the same.
Opening claim text (preview).
The invention claimed is: 1. A composition for interfacial polymerizing polyamide comprising: an amine compound; and one or more types of compounds selected from among a purine-based compound and a pyrimidine-based compound, wherein the purine-based compound is one or more selected from among purine, adenine, guanine, hypoxanthine, xanthine, theobromine, caffeine, uric acid and isoguanine, wherein the pyrimidine-based compound is one or more selected from among uracil, cytosine and thymine, wherein the purine-based compound is present in an amount from 0.001 wt % to 1 wt % based on 100 wt % of the composition, wherein the pyrimidine-based compound is present in an amount from 0.001 wt % to 1 wt % based on 100 wt % of the composition; and wherein, when the composition is contacted with an organic solution containing an acyl halide, an interfacial polymerization forms a polyamide active layer. 2. The composition of claim 1 comprising the purine-based compound and the pyrimidine-based compound, wherein a total amount of the purine-based compound and the pyrimidine-based compound is from 0.01 wt % to 0.2 wt % based on 100 wt % of the composition. 3. The composition of claim 1 , wherein the amine compound is present in an amount from 0.1 wt % to 20 wt % based on 100 wt % of the composition. 4. The composition claim 1 , further comprising a surfactant, wherein the surfactant is present in an amount from 0.01 wt % to 1 wt % based on 100 wt % of the composition.
by interfacial polymerisation · CPC title
Woven, non-woven or net mesh · CPC title
Preparatory processes · CPC title
Reverse osmosis; Hyperfiltration · CPC title
by chemical reactions (in-situ polymerisation, polycondensation, cross-linking or reaction for manufacturing composite membranes B01D69/125) · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.